pUBC_IGF2BP2(IMP2)_serinemod_E488QADAR_p2A_yGFP
(Plasmid
#247301)
-
PurposeExpresses Igf2bp2 (IMP2) fused to hyperactive ADAR catalytic domain, mammalian expression vector for HyperTRIBE
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 247301 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepUBC_mCherry_serinemod_E488QADAR_p2A_yGFP (Addgene Plasmid #154786)
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAdenosine deaminse acting on RNA
-
Alt nameADAR
-
SpeciesD. melanogaster (fly), Synthetic
-
Insert Size (bp)1281
-
MutationE488Q, hyperactive variant
-
Entrez GeneAdar (a.k.a. Dmel_CG12598, ADAR, ADAR1, CG12598, Dmel\CG12598, EG:BACN35H14.1, adar, adr, cg12598, dADAR, dAdar, dadar, hypnos-2)
- Promoter UBC
-
Tags
/ Fusion Proteins
- GFP (C terminal on insert)
- V5 (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NotI (not destroyed)
- 3′ cloning site PshA1 (not destroyed)
- 5′ sequencing primer UBC_F (5'-CGCCGATGATTATATAAGGA-3')
- 3′ sequencing primer GFP_R (5'-GCATCACCTTCACCTTCACC-3')
- (Common Sequencing Primers)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pUBC_IGF2BP2(IMP2)_serinemod_E488QADAR_p2A_yGFP was a gift from Robert Singer (Addgene plasmid # 247301 ; http://n2t.net/addgene:247301 ; RRID:Addgene_247301) -
For your References section:
HyperTRIBE identifies hepatic IGF2BP2/IMP2 targets in vivo and links IMP2 to autophagy. Do HTT, Both S, Kröhler T, Pirritano M, Wonterghem EV, Raab E, Ahne L, Franzenburg S, Ibrahim EM, Simon M, Biswas J, Helms V, Kessler SM, Kiemer AK. NAR Mol Med, 2026 10.1093/narmme/ugag034